Weight-Loss drugs under the microscope: new study tracks diet and body changes

NCT ID NCT07270497

First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 20 times

Summary

This study looks at how GLP-1 and GIP/GLP-1 medications affect what people eat, their metabolism, and behavior over a year. About 100 adults with overweight or obesity will be followed before starting treatment and at 3, 6, and 12 months. Researchers will measure weight loss, body composition, diet quality, appetite, and side effects to understand the full impact of these drugs.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLP-1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Klinika Diabetologii i Chorób Wewnętrznych Uniwersyteckiego Centrum Klinicznego Warszawskiego Uniwersytetu Medycznego

    RECRUITING

    Warsaw, Warszawa, 02-097, Poland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.